Showing 2901-2910 of 8250 results for "".
Point/Counterpoint: MMC—Friend or Foe in Refractive Surgery? Part 1
https://crstoday.com/crst-issues/2002-jul/crst0702_05-php/40130/Mitomycin C is a safe and effective adjunct to “high-risk” cases of PRK and LASEK.Refractive Challenge
https://crstoday.com/crst-issues/2002-sep/0902_111-html/40108/Interface HazeThe Potential of Mitomycin C
https://crstoday.com/crst-issues/2001-oct/1_1001_17-html/40048/Applications could broaden for this popular antimetabolite.A Presumptive Diagnosis of DLK
https://crstoday.com/crst-issues/2001-nov/1_1101_10-html/40019/Neglecting critical steps can delay treatment and provide a disastrous result.Five Key Strategies for a Greener Practice
https://crstoday.com/crst-issues/jan-2024/five-key-strategies-for-a-greener-practice/45205/A detailed examination of the strategies and collaborative efforts needed to minimize waste, enhance energy efficiency, and promote sustainable practices in ophthalmology.New Approaches to Drug Delivery
https://crstoday.com/topics/cataract-surgery/new-approaches-to-drug-delivery/44271/Best Practices & Experience with SMILE
https://crstoday.com/crst-supplements/best-practices-experience-with-smile/best-practices-experience-with-smile-2/44245/A panel of experienced users provide their thoughts on the one-step refractive surgical procedure.Strategies for Success With Five Refractive IOLs
https://crstoday.com/topics/general/crst0209_09-php/41709/IOL Options in 2008
https://crstoday.com/topics/general/crst0108_07-php/41515/Global Perspectives
https://crstoday.com/crst-issues/2020-june/global-perspectives/44258/How eye care practitioners from around the world are dealing with the return to practice.